May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study has unveiled the industries most susceptible to cyberattacks. Alarmingly, the healthcare sector has been revealed as the most vulnerable, underscoring the urgent need for heightened security within healthcare companies.

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next Gen Basketball Players Union (NBGPU) in collaboration with GE HealthCare and MedStar Health announced the completion of the data collection phase of a longitudinal pilot study of NBA G League players.

Radiology, once confined to dark rooms with X-ray films hanging from light boxes, has transformed at a rapid-fire pace over the past few decades. Today, it stands at the forefront of medical innovation, driven by technological advancements and in keeping pace with ever-evolving healthcare needs. 

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients receiving care at accredited cancer hospitals in Pennsylvania, according to a study published in Health Services Research by 

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic radiology programs, as are underrepresented minorities compared to their White counterparts, according to research presented at the 124th ARRS Annual Meeting.

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, announced the signing of a non-exclusive data-sharing agreement with Siemens Healthineers for anonymized

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance, significantly improved visualization of focal liver lesions, successfully meeting the primary endpoint in the pivotal Phase 3 study SPARKLE.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now